3/15
12:47 pm
life
Rating for LIFE
Medium
Report
Rating for LIFE
3/15
12:47 pm
life
Rating for LIFE
Medium
Report
Rating for LIFE
2/21
11:17 am
life
aTyr Pharma, Inc. (NASDAQ: LIFE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $35.00 price target on the stock.
Low
Report
aTyr Pharma, Inc. (NASDAQ: LIFE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $35.00 price target on the stock.